ONCPLASTY Trademark

Trademark Overview

On Thursday, November 11, 2021, a trademark application was filed for ONCPLASTY with the United States Patent and Trademark Office. The USPTO has given the ONCPLASTY trademark a serial number of 97119583. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, August 21, 2024. This trademark is owned by Zetagen Therapeutics, Inc.. The ONCPLASTY trademark is filed in the Medical Instrument Products category with the following description:

Medical kits comprised of cannulae, surgical pushers, surgical needles, and syringes used for the delivery of pharmaceutical products for the treatment of bone diseases and metastatic tumors
oncplasty

General Information

Serial Number97119583
Word MarkONCPLASTY
Filing DateThursday, November 11, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesMedical kits comprised of cannulae, surgical pushers, surgical needles, and syringes used for the delivery of pharmaceutical products for the treatment of bone diseases and metastatic tumors

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZetagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210
Party NameZetagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Trademark Events

Event DateEvent Description
Monday, November 15, 2021NEW APPLICATION ENTERED
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 9, 2023SOU EXTENSION 1 FILED
Thursday, March 9, 2023SOU EXTENSION 1 GRANTED
Saturday, March 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU EXTENSION 2 FILED
Thursday, September 14, 2023SOU EXTENSION 2 GRANTED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

oncplasty surgical treatment products pharmaceutical bone delivery metastatic diseases tumors used